Addus HomeCare Co. (NASDAQ:ADUS) Given Consensus Rating of “Moderate Buy” by Analysts

Addus HomeCare Co. (NASDAQ:ADUS) has earned an average recommendation of “Moderate Buy” from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $131.63.

A number of research analysts recently issued reports on ADUS shares. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Tuesday. Macquarie reissued an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer lifted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. Finally, Stephens lifted their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th.

Addus HomeCare Trading Up 0.4 %

NASDAQ:ADUS opened at $120.74 on Friday. The company has a 50-day moving average price of $126.26 and a 200-day moving average price of $123.97. Addus HomeCare has a 12 month low of $85.94 and a 12 month high of $136.12. The stock has a market cap of $2.19 billion, a price-to-earnings ratio of 27.63, a P/E/G ratio of 2.14 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same period last year, the company posted $1.03 EPS. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. Equities analysts forecast that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This represents a 12.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

A number of large investors have recently made changes to their positions in ADUS. Ellsworth Advisors LLC bought a new stake in Addus HomeCare during the second quarter valued at approximately $598,000. SG Americas Securities LLC bought a new stake in Addus HomeCare during the second quarter valued at approximately $842,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Addus HomeCare during the third quarter valued at approximately $1,622,000. Dimensional Fund Advisors LP grew its position in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after buying an additional 5,421 shares during the period. Finally, Argent Capital Management LLC grew its position in Addus HomeCare by 51.5% during the second quarter. Argent Capital Management LLC now owns 37,310 shares of the company’s stock valued at $4,332,000 after buying an additional 12,685 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.